383
Views
44
CrossRef citations to date
0
Altmetric
Original

CONNECTIVE TISSUE GROWTH FACTOR AND ITS REGULATION: A NEW ELEMENT IN DIABETIC GLOMERULOSCLEROSIS

&
Pages 459-470 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Huankai Yao, Wenting Zhang, Feng Yang, Fengwei Ai, Dan Du & Yan Li. (2022) Discovery of caffeoylisocitric acid as a Keap1-dependent Nrf2 activator and its effects in mesangial cells under high glucose. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 178-188.
Read now
Yuji Naito, Kazuhiko Uchiyama, Masaaki Kuroda, Katsura Mizushima, Wataru Aoi, Satoshi Kokura, Hiroshi Ichikawa, Norimasa Yoshida & Toshikazu Yoshikawa. (2004) Laser capture microdissection/GeneChip analysis of gene expression in glomerular cells in diabetic db/db mice. Redox Report 9:6, pages 307-312.
Read now

Articles from other publishers (41)

Julian E.A. Leakey, A. Afshan Ali, Amy R. Babb, Heidi L. Badgley, Kelly J. Davis, Beth E. Juliar, Tatiana I. Leakey, Sherry M. Lewis, Ralph E. Patton & John E. Seng. (2021) Subchronic toxicity evaluation of glucosamine and glucosamine in combination with chondroitin sulfate in obese Zucker rats. Toxicology and Applied Pharmacology 412, pages 115371.
Crossref
Andrew G. Mtewa, Amanjot Annu, Anke Weisheit, Casim U. Tolo & Patrick E. Ogwang. 2021. Preparation of Phytopharmaceuticals for the Management of Disorders. Preparation of Phytopharmaceuticals for the Management of Disorders 373 380 .
Eun-Jung Lee, Min-Kyung Kang, Dong Kim, Yun-Ho Kim, Hyeongjoo Oh & Young-Hee Kang. (2018) Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys. Nutrients 10:7, pages 882.
Crossref
Bruce L. Riser, Feridoon Najmabadi, Kendra Garchow, Jeffrey L. Barnes, Darryl R. Peterson & Ernest J. Sukowski. (2014) Treatment with the Matricellular Protein CCN3 Blocks and/or Reverses Fibrosis Development in Obesity with Diabetic Nephropathy. The American Journal of Pathology 184:11, pages 2908-2921.
Crossref
Radko Komers, Bei Xu, Yi Fu, Aaron McClelland, Phillip Kantharidis, Amit Mittal, Herbert T. Cohen & David M. Cohen. (2014) Transcriptome-Based Analysis of Kidney Gene Expression Changes Associated with Diabetes in OVE26 Mice, in the Presence and Absence of Losartan Treatment. PLoS ONE 9:5, pages e96987.
Crossref
Noel Faherty, Helen O’Donovan, David Kavanagh, Stephen Madden, Gareth J McKay, Alexander P Maxwell, Finian Martin, Catherine Godson & John Crean. (2013) TGFβ and CCN2/CTGF mediate actin related gene expression by differential E2F1/CREB activation. BMC Genomics 14:1.
Crossref
Jing Li, Min-Kyung Kang, Jin-Kyu Kim, Jung-Lye Kim, Sang-Wook Kang, Soon Sung Lim & Young-Hee Kang. (2011) Purple corn anthocyanins retard diabetes-associated glomerulosclerosis in mesangial cells and db/db mice. European Journal of Nutrition 51:8, pages 961-973.
Crossref
Jing Li, Soon Sung Lim, Jae-Yong Lee, Jin-Kyu Kim, Sang-Wook Kang, Jung-Lye Kim & Young-Hee Kang. (2012) Purple corn anthocyanins dampened high-glucose-induced mesangial fibrosis and inflammation: possible renoprotective role in diabetic nephropathy. The Journal of Nutritional Biochemistry 23:4, pages 320-331.
Crossref
Volker Vallon & Radko Komers. 2011. Comprehensive Physiology. Comprehensive Physiology 1175 1232 .
Akhtar A. Ali, Sherry M. Lewis, Heidi L. Badgley, William T. Allaben & Julian E.A. Leakey. (2011) Oral glucosamine increases expression of transforming growth factor β1 (TGFβ1) and connective tissue growth factor (CTGF) mRNA in rat cartilage and kidney: Implications for human efficacy and toxicity. Archives of Biochemistry and Biophysics 510:1, pages 11-18.
Crossref
Akhtar Ali, William Salminen & Julian Leakey. 2011. Arthritis. Arthritis 261 282 .
Stephen M. Twigg. (2010) Mastering a mediator: blockade of CCN-2 shows early promise in human diabetic kidney disease. Journal of Cell Communication and Signaling 4:4, pages 189-196.
Crossref
Bruce L. Riser, Feridoon Najmabadi, Bernard Perbal, Jo Ann Rambow, Melisa L. Riser, Ernest Sukowski, Herman Yeger, Sarah C. Riser & Darryl R. Peterson. (2010) CCN3/CCN2 regulation and the fibrosis of diabetic renal disease. Journal of Cell Communication and Signaling 4:1, pages 39-50.
Crossref
Bruce. L. Riser, Feridoon Najmabadi, Bernard Perbal, Jo Ann Rambow, Melisa L. Riser, Ernest Sukowski, Herman Yeger, Sarah C. Riser & Darryl R. Peterson. 2010. CCN Proteins in Health and Disease. CCN Proteins in Health and Disease 163 181 .
Bruce L. Riser, Feridoon Najmabadi, Bernard Perbal, Darryl R. Peterson, Jo Ann Rambow, Melisa L. Riser, Ernest Sukowski, Herman Yeger & Sarah C. Riser. (2009) CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease. The American Journal of Pathology 174:5, pages 1725-1734.
Crossref
Luigi Gnudi. (2008) Molecular mechanisms of proteinuria in diabetes. Biochemical Society Transactions 36:5, pages 946-949.
Crossref
Esther J. Kuiper, Rogier van Zijderveld, Peggy Roestenberg, Karen M. Lyons, Roel Goldschmeding, Ingeborg Klaassen, Cornelis J. F. Van Noorden & Reinier O. Schlingemann. (2008) Connective Tissue Growth Factor Is Necessary for Retinal Capillary Basal Lamina Thickening in Diabetic Mice. Journal of Histochemistry & Cytochemistry 56:8, pages 785-792.
Crossref
Jamal Ahmad. (2008) Renin–angiotensin system blockade in diabetic nephropathy. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2:2, pages 135-158.
Crossref
W.H. Yiu, C.-J. Pan, R.A. Ruef, W.-T. Peng, M.F. Starost, B.C. Mansfield & J.Y. Chou. (2008) Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia. Kidney International 73:6, pages 716-723.
Crossref
J. M. Hughes, E. J. Kuiper, I. Klaassen, P. Canning, A. W. Stitt, J. Van Bezu, C. G. Schalkwijk, C. J. F. Van Noorden & R. O. Schlingemann. (2007) Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina. Diabetologia 50:5, pages 1089-1098.
Crossref
Sara GiuntiDavid BaritMark E. Cooper. (2006) Mechanisms of Diabetic Nephropathy. Hypertension 48:4, pages 519-526.
Crossref
Brahim Chaqour & Margarete Goppelt-Struebe. (2006) Mechanical regulation of the Cyr61/CCN1 and CTGF/CCN2 proteins.. FEBS Journal 273:16, pages 3639-3649.
Crossref
Joshua J. Wang, Sarah X. Zhang, Robert Mott, Ryan R. Knapp, Wei Cao, Kai Lau & Jian-xing Ma. (2006) Salutary Effect of Pigment Epithelium–Derived Factor in Diabetic Nephropathy. Diabetes 55:6, pages 1678-1685.
Crossref
Vera Portik-Dobos, Alex K. Harris, Weiwei Song, Jimmie Hutchinson, Maribeth H. Johnson, John D. Imig, David M. Pollock & Adviye Ergul. (2006) Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 290:2, pages R435-R441.
Crossref
Luigi Gnudi & Leopoldo Raij. (2006) The link between Glut-1 and hypertension in diabetic nephropathy. Current Hypertension Reports 8:1, pages 79-83.
Crossref
Steen Andersen, Frans A. van Nieuwenhoven, Lise Tarnow, Peter Rossing, Kasper Rossing, Lotte Wieten, Roel Goldschmeding & Hans-Henrik Parving. (2005) Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy. Kidney International 67:6, pages 2325-2329.
Crossref
Chu-I Lee, Jinn-Yuh Guh, Hung-Chun Chen, Wen-Chun Hung, Yu-Lin Yang & Lea-Yea Chuang. (2005) Advanced glycation end-product-induced mitogenesis and collagen production are dependent on angiotensin II and connective tissue growth factor in NRK-49F cells. Journal of Cellular Biochemistry 95:2, pages 281-292.
Crossref
Mimi Sohn, Yan Tan, Richard L. Klein & Ayad A. Jaffa. (2005) Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells. Kidney International 67:4, pages 1286-1296.
Crossref
Amy W. Rachfal & David R. Brigstock. 2005. 69 103 .
Guihua Zhou, Cai Li & Lu Cai. (2004) Advanced Glycation End-Products Induce Connective Tissue Growth Factor-Mediated Renal Fibrosis Predominantly through Transforming Growth Factor β-Independent Pathway. The American Journal of Pathology 165:6, pages 2033-2043.
Crossref
Chu‐I Lee, Jinn‐Yuh Guh, Hung‐Chun Chen, Kuan‐Hua Lin, Yu‐Lin Yang, Wen‐Chun Hung, Yung‐Hsiung Lai & Lea‐Yea Chuang. (2004) Leptin and connective tissue growth factor in advanced glycation end‐product‐induced effects in NRK‐49F cells. Journal of Cellular Biochemistry 93:5, pages 940-950.
Crossref
T. S. Polhill, S. Saad, P. Poronnik, G. R. Fulcher & C. A. Pollock. (2004) Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposure. American Journal of Physiology-Renal Physiology 287:2, pages F268-F273.
Crossref
Juliane Heusinger-Ribeiro, Barbara Fischer & Margarete Goppelt-Struebe. (2004) Differential effects of simvastatin on mesangial cells. Kidney International 66:1, pages 187-195.
Crossref
Ye Song, Cai Li & Lu Cai. (2004) Fluvastatin prevents nephropathy likely through suppression of connective tissue growth factor-mediated extracellular matrix accumulation. Experimental and Molecular Pathology 76:1, pages 66-75.
Crossref
Sheldon Chen, Belinda Jim & Fuad N Ziyadeh. (2003) Diabetic nephropathy and transforming growth factor-β: transforming our view of glomerulosclerosis and fibrosis build-up. Seminars in Nephrology 23:6, pages 532-543.
Crossref
Monica Rupérez, Marta Ruiz-Ortega, Vanesa Esteban, Óscar Lorenzo, Sergio Mezzano, Juan Jose Plaza & Jesús Egido. (2003) Angiotensin II Increases Connective Tissue Growth Factor in the Kidney. The American Journal of Pathology 163:5, pages 1937-1947.
Crossref
Bruce L. Riser, Pedro Cortes, Mark Denichilo, Poornima V. Deshmukh, Parminder S. Chahal, Ali K. Mohammed, Jerry Yee & Dorothy Kahkonen. (2003) Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: Preliminary report. Kidney International 64:2, pages 451-458.
Crossref
Benjamin S. Weston, Nadia Abdel Wahab & Roger M. Mason. (2003) CTGF Mediates TGF-β–Induced Fibronectin Matrix Deposition by Upregulating Active α5β1 Integrin in Human Mesangial Cells. Journal of the American Society of Nephrology 14:3, pages 601-610.
Crossref
John K.G. Crean, Darren Finlay, Madeline Murphy, Catherine Moss, Catherine Godson, Finian Martin & Hugh R. Brady. (2002) The Role of p42/44 MAPK and Protein Kinase B in Connective Tissue Growth Factor Induced Extracellular Matrix Protein Production, Cell Migration, and Actin Cytoskeletal Rearrangement in Human Mesangial Cells. Journal of Biological Chemistry 277:46, pages 44187-44194.
Crossref
Elizabeth Gore-Hyer, Daniel Shegogue, Malgorzata Markiewicz, Shianlen Lo, Debra Hazen-Martin, Eddie L. GreeneGary Grotendorst & Maria Trojanowska. (2002) TGF-β and CTGF have overlapping and distinct fibrogenic effects on human renal cells. American Journal of Physiology-Renal Physiology 283:4, pages F707-F716.
Crossref
Youjun Chen, Ingrid E. Blom, Susan Sa, Roel Goldschmeding, David J. Abraham & Andrew Leask. (2002) CTGF expression in mesangial cells: Involvement of SMADs, MAP kinase, and PKC. Kidney International 62:4, pages 1149-1159.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.